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In Brief
Our high-resolution analysis of human chr21 reveals a fundamental distinction in the architecture of protein-coding and noncoding gene content. Contrary to the impression from more shallow surveys, noncoding RNAs exhibit enriched splicing diversity, with noncoding exons (but not protein-coding counterparts) being near-universally alternatively spliced.
INTRODUCTION
The genome is transcribed into a diverse range of protein-coding and noncoding RNAs collectively termed the transcriptome. The human transcriptome is so large and complex that, even after a decade of investigation by RNA sequencing (RNA-seq), we are yet to achieve a complete census of gene expression. Moreover, our view of a gene as a discrete entity, and of a single proteincoding gene as the functional unit of inheritance, has been undermined by the recognition of pervasive transcription across the genome and interleaved alternative isoforms at individual loci (Carninci et al., 2005; Clark et al., 2011; Djebali et al., 2012; Kapranov et al., 2005; Mercer et al., 2011; Sharon et al., 2013; Tilgner et al., 2015) .
RNA-seq has revealed an abundance of small and large nonprotein-coding RNAs that are antisense, intronic, or intergenic to protein-coding genes (Derrien et al., 2012; Hon et al., 2017; Iyer et al., 2015; You et al., 2017) . Similarly, many protein-coding genes express alternative isoforms that lack extended open reading frames (ORFs; Gonzà lez- Porta et al., 2013) . These findings have fueled one of the major debates of modern genetics: the functional relevance of noncoding RNA expression.
The initial sequencing of the human genome provided a catalog of around 20,000 protein-coding genes (Lander et al., 2001) . However, at least as many long noncoding RNAs (lncRNAs) have since been identified, and new studies routinely discover novel genes and isoforms (Hon et al., 2017; Iyer et al., 2015; Sharon et al., 2013; Tilgner et al., 2015; You et al., 2017) . This failure to achieve a comprehensive annotation of the transcriptome is partly due to the expression-dependent bias of RNA-seq, which limits the capacity of this technique to resolve low-abundance transcripts (Hardwick et al., 2016) . This has impeded the discovery and characterization of lncRNAs, which are typically weakly expressed (Cabili et al., 2011; Derrien et al., 2012) . As a result, our understanding of lncRNA biology has been largely informed by studying only those examples with sufficient expression for analysis by RNA-seq.
Another limitation of traditional RNA-seq is the reliance on computational assembly of full-length isoforms from short (100-150 bp) sequencing reads. This is a difficult task, particularly when alternative splicing generates multiple partially redundant isoforms at an individual locus (Conesa et al., 2016) . With the emergence of technologies for long-read sequencing it is now possible to read full-length isoforms as single molecules, negating the challenges posed by transcript assembly. Leading studies have highlighted the utility of single-molecule techniques for resolving complex and precisely organized alternative splicing events (Sharon et al., 2013; Tilgner et al., 2015) . However, depth remains a constraint, with rare transcripts often falling below the limits of sampling.
Here, we have attempted to reach the lower limits of the transcriptome by surveying gene expression from a single human chromosome at unprecedented resolution. Chromosome 21 (Hsa21) is the smallest human chromosome (48 Mb) , is typical of the human genome in many features (e.g., gene content and repeat density; Figure S1 ), and has accordingly been used as a model system in transcriptomics Kampa et al., 2004) . With trisomy of Hsa21 being the most common chromosomal aneuploidy in live-born children and the most frequent genetic cause of mental retardation, the gene content of this chromosome is also the subject of medical interest (Dierssen, 2012; Letourneau et al., 2014) .
To resolve the complete expression profile of Hsa21 while excluding the remainder of the genome, we used targeted RNA-seq (CaptureSeq; Mercer et al., 2014) . Complementary oligonucleotide probes were tiled across the chromosome to capture expressed transcripts that were then sequenced deeply on single-molecule and short-read platforms. This approach reduces the influence of the expression-dependent bias inherent to RNA-seq, allowing gene populations encoded within this cross-section of the genome to be observed at high resolution. This reveals a fundamental distinction in the architecture of protein-coding and noncoding RNA.
RESULTS
Targeted RNA-Seq Analysis of Human Chromosome 21 Two limitations of traditional RNA-seq have ensured that, despite considerable attention, the true dimensions of the human transcriptome remain unresolved. First, because sequencing reads are competitively sampled from a single pool in which transcripts of varied abundance are proportionally represented, weakly expressed transcripts commonly evade detection (Clark et al., 2011; Hardwick et al., 2016) . Second, the accurate assembly of full-length isoforms from short sequencing reads is challenging, particularly when multiple alternative isoforms are transcribed from a single locus (Conesa et al., 2016; Tilgner et al., 2015) .
To address these challenges, we performed single-molecule (PacBio RSII) and short-read (Illumina HiSeq) RNA CaptureSeq, targeting the complete expression profile of Hsa21. We generated biotin-labeled oligonucleotide probes tiling the entire nonrepetitive Hsa21 sequence. These were used to capture full-length cDNA molecules, thereby restricting sequencing to transcripts expressed on Hsa21 (STAR Methods).
To establish our approach, we first performed short-read sequencing on Hsa21-enriched cDNA libraries from the human K562 cell type and compared these with K562 samples analyzed in parallel by conventional RNA-seq (STAR Methods). Whereas just 1.3% of reads from RNA-seq libraries were uniquely aligned to Hsa21, this figure rose to 71.8% after capture, equating to a 54-fold coverage enrichment (Table S1 ). Analysis of ERCC (External RNA Controls Consortium) spike-in controls confirmed that RNA CaptureSeq accurately measured transcript abundances within the physiological range of gene expression (Figures S2A and S2B) , as previously demonstrated (Clark et al., 2015; Mercer et al., 2014) . The legitimacy of novel splice junctions identified by CaptureSeq was also verified by RT-PCR and Sanger sequencing (16 of 20 randomly selected examples; Figure S2C and Table S2 ).
Next, we analyzed Hsa21-enriched cDNA from human testis by deep single-molecule sequencing (STAR Methods). Testis exhibits a distinctly promiscuous transcriptional profile (Soumillon et al., 2013) , marking this as an ideal tissue within which to conduct a broad survey of gene content encoded on Hsa21. We obtained 387,029 full-length nonchimeric reads aligning to Hsa21, representing 910 Mb of usable transcript sequence concentrated in 1.5% of the genome. After filtering, we retrieved 101,478 full-length multi-exonic transcript reads on Hsa21 (Table S3 ; Figures S3A and S3B).
To reinforce single-molecule isoforms and, more importantly, enable quantitative analyses of expression and splicing, we also performed very deep short-read sequencing on Hsa21-enriched cDNA from testis, brain, and kidney (STAR Methods). An average 65-fold coverage enrichment, relative to conventional RNA-seq, was achieved, and at least 100 million reads uniquely aligning to Hsa21 were obtained for each tissue (Table S4) . Strong correspondence between spliced short-read alignments and single-molecule transcripts in our Hsa21 transcriptome profile was observed, with 84.7% of alignment junctions being concordant with introns in single-molecule transcripts (Figures S3C and S3D) . Because long PacBio reads provide reliable transcript scaffolds, while read counts for short Illumina reads accurately estimate the abundance of known isoforms, our combined CaptureSeq approach permits robust quantitative transcriptome analyses that do not rely on de novo transcript assembly.
Transcriptional Landscape of Human Chromosome 21
Hsa21 has frequently been used as a cross-sectional model for genomics because it is small (48 Mb; 1.5% of the genome) and typical in terms of gene content, repeat density, and other features ( Figure S1 ; Cawley et al., 2004; Kampa et al., 2004) .
Our targeted analysis showed that essentially all (nonrepetitive) regions of Hsa21 encode spliced gene loci, greatly reducing intergenic regions ( Figure 1A ). This is best illustrated in two ''gene deserts'' that flank the NCAM2 gene (extending 2.6 Mb upstream and 4.0 Mb downstream), which were largely devoid of transcript annotations. We discovered that these regions harbored numerous large, multi-exonic, and richly alternatively spliced lncRNAs ( Figure 1B) .
At protein-coding loci on Hsa21 we identified 7,310 unique multi-exonic isoforms, of which 77% were novel, with respect to current annotations (a combined transcriptome catalog of Gencode v19, MiTranscriptome v2, and FANTOM5; Figure 1C ; Tables S5 and S6 ). Novel isoforms encoded up to 2,365 possible ORFs that were not currently annotated, encompassing 291 novel coding exons and 845 novel ORF introns ( Figure 1C ; for examples see Figure S4 ). Although these are predicted ORFs only, and the precise number retrieved is influenced by the choice of cutoff parameters (STAR Methods), this represents a considerable increase on existing annotations. (legend continued on next page) While this suggests that the protein-coding content of Hsa21 may be underestimated, most novel isoforms to protein-coding genes were noncoding isoform variants or possessed novel UTRs. Alternative splicing of UTRs (both 5 0 and 3 0 ) was common and often highly complex (for examples see Figure S5 ). Singlemolecule sequencing was particularly useful for resolving UTR variants, since it does not suffer from sequencing ''edge effects'' that affect short-read transcript assembly (Martin and Wang, 2011) . In total, protein-coding loci on Hsa21 encoded 3,931 unique internal exons (34% novel) and 6,365 unique canonical introns (43% novel; Figure 1C ; Tables S5 and S6) .
At noncoding loci, we identified 1,589 isoforms across Hsa21, encompassing 1,663 unique internal exons (45% novel) and 3,210 unique canonical introns (55% novel; Figure 1C ; Tables  S5 and S6 ). Examples of rich isoform diversity at lncRNA loci were routinely resolved with targeted single-molecule sequencing (Figures 1B and S6) . In many instances, multiple partial lncRNA annotations were incorporated into single unified loci ( Figures S6A-S6C ), and the splicing of lncRNAs with neighboring protein-coding genes to form extensively spliced UTRs was also frequently observed ( Figure S6D ).
By extrapolating our Hsa21 annotations across the broader human genome, we can estimate the existence of 383,000 unique isoforms to protein-coding genes that encompass 147,000 possible ORFs. We predict noncoding gene loci to express 98,000 multi-exonic isoforms (2.1-fold increase by comparison with Gencode v26), incorporating 88,000 internal exons (1.2-fold) and 168,000 introns (1.7-fold). While we have profiled only three tissues, ensuring that these are lower-bound estimates, it is clear that a large amount of transcriptional diversity remains unexplored.
Universal Alternative Splicing of Noncoding Exons
To determine whether RNA CaptureSeq provided a complete profile of transcription on Hsa21, or whether further isoforms remain to be discovered, we generated discovery-saturation curves by incremental subsampling of short-read alignments (STAR Methods). The detection of protein-coding exons and introns approached saturation at a fraction of library depth, indicating that these were near comprehensively sampled (Figure 2A ; note that terminal exons were not considered in this analysis). While the detection of noncoding exons also approached saturation, the discovery of noncoding introns (and consequently additional noncoding isoforms) continued progressively toward maximum sequencing depth (Figure 2A ). This indicates that although the majority of exons were discovered, noncoding isoforms were not exhaustively resolved, even with the enhanced sensitivity afforded by RNA CaptureSeq.
Because each unique intron represents a different splicing event, this result suggests that alternative splicing generates a seemingly limitless diversity of noncoding isoform variants. To confirm this, we assessed the alternative splicing of internal exons according to percent splice inclusion (PSI) scores (STAR Methods). Unlike protein-coding exons (median PSI = 90.5%), almost all noncoding exons were alternatively spliced (median PSI = 55.5%; Figures 2B and S7 ). The relative abundances of coding and noncoding introns, compared with exons, further supports this finding; we found that the relative difference between coding and noncoding introns (49.8-fold) is larger than for exons (19.2-fold; Figure 2C ), reflecting the greater isoform diversity generated by enriched alternative splicing of noncoding RNAs. We use the phrase universal alternative splicing to mean that nearly every noncoding exon is subject to alternative splicing.
The distinction between coding and noncoding splicing is illustrated by comparison of the protein-coding gene SAMSN1 with its antisense lncRNA (SAMSN1-AS1) and a nearby intergenic lncRNA (AJ006998.2). While the majority of single-molecule SAMSN1 transcripts correspond to one of just two mRNA isoforms for this gene, almost all SAMSN1-AS1 and AJ006998.2 transcript molecules represent unique isoforms ( Figure 2D ). Universal alternative splicing was not limited to lncRNA exons but was similarly observed for untranslated exons at protein-coding loci (located in 5 0 or 3 0 UTRs, or specific to noncoding isoforms; Figures S8 and S9 ). For example, the 5 0 UTR of the protein-coding gene CHODL exhibited extensive alternative splicing ( Figure S10 ). Splice acceptor sites at lncRNA and UTR exons harbored canonical splicing elements that were indistinguishable from those found at protein-coding exons ( Figure S8B ), confirming that noncoding exons are demarcated by bona fide rather than cryptic splice sites.
Our analysis reveals a fundamental distinction between the organization of protein-coding and noncoding gene content. While the diversity of protein-coding isoforms is limited by the requirement to maintain an ORF, no such constraint is imposed on noncoding RNA, allowing the spliceosome to explore the full range of noncoding exon combinations to generate an effectively inexhaustible noncoding isoform diversity. It is worth noting here that this phenomenon is not limited to obscure noncoding RNAs encoded on Hsa21: using publicly available data (Cabili et al., 2011; Clark et al., 2015; Iyer et al., 2015) we examined four well-known functional lncRNAs-XIST, HOTAIR, GOMAFU, and H19-and revealed rich isoform diversity and near-universal alternative splicing at each locus ( Figure S11 ).
Comparison of Transcriptional Landscapes in Human and Mouse
To establish whether the novel genes and isoforms unearthed on Hsa21 were conserved between human and mouse, and to determine whether noncoding exons are similarly enriched for (B) Inset from (A): detail of intergenic regions flanking the protein-coding gene NCAM2 (2.6 Mb upstream and 4.0 Mb downstream), in which multiple novel long noncoding RNAs (lncRNAs) were detected. Red and blue insets show single-molecule reads supporting NCAM2 (blue) and two nearby lncRNAs (red). Singlemolecule RNA CaptureSeq data extend the gene model for the previously annotated lncRNA AP000946.2 and resolve a novel lncRNA that is transcribed in the opposite direction. Both exhibit extensive alternative splicing, in contrast to NCAM2, where the majority of reads represents redundant isoforms. (C) The number of unique internal exons, unique canonical introns, and nonredundant isoforms resolved by single-molecule RNA CaptureSeq. Content from protein-coding genes (upper) and noncoding loci (lower) are shown separately and, for protein-coding genes, exons/introns belonging to noncoding isoforms or UTR variants (green) are distinguished from predicted ORFs (blue). (D) The proportion of captured bases on Hsa21 that are exonic, intronic, or silent, according to Gencode (v19; left) and RNA CaptureSeq (right). alternative splicing, we performed short-read RNA CaptureSeq across mouse genome regions syntenic to Hsa21 (located on mouse chromosomes 10, 16, and 17; Mouse Genome Sequencing Consortium et al., 2002) . We obtained transcriptional profiles of equivalent depth to human samples within matched mouse tissues (Table S7) , enabling comparison of the two transcriptomes at high resolution (STAR Methods).
As for Hsa21, the syntenic regions of the mouse genome were pervasively transcribed, largely eroding intergenic desert regions ( Figure 3A smaller than human (77%, based on unique internal exon count; Table S8 ). Although almost all protein-coding genes on Hsa21 have mouse orthologs, we observed a higher frequency of alternative splicing among human genes than their mouse counterparts: 69% of human protein-coding exons were classified as alternative (PSI < 95%) compared with just 31% in mouse ( Figure 2B ). As a result of this greater splicing diversity, human protein-coding genes had more internal exons (17%), introns (39%), and isoforms (65%) than their corresponding mouse orthologs (Table S8 ).
The DYRK1A gene, a leading candidate for autism and trisomy-21 phenotypes (Becker et al., 2014) , provides an illustrative example of the increased splicing diversity distinguishing human genes from their mouse orthologs. While we found no novel exons or isoforms to the Dyrk1A gene in the mouse, we identified six novel internal exons in the human brain (in addition to all 13 currently annotated DYRK1A exons; Figures 4A and 4B ). Extensive alternative splicing generated at least 11 novel DYRK1A isoforms, of which 10 comprise noncoding variants and one encodes a novel ORF with an N-terminal modification to the DYRK1A protein ( Figures 4A and 4B ; interestingly, an analogous N-terminal modification regulates subcellular localization of the DYRK4 paralog [Papadopoulos et al., 2011] ).
The majority of novel exons discovered in the mouse syntenic regions were noncoding ( Figure 3B ), and these were similarly subject to near-universal alternative splicing ( Figure 2B ). This indicates that the size and structure of the human and mouse transcriptomes are largely comparable, with each harboring large noncoding RNA populations that exhibit prolific alternative splicing.
Despite this similarity, we found that individual lncRNAs were largely divergent between the two lineages (STAR Methods). Nineteen percent of lncRNA splice-acceptor and 16% of splice-donor dinucleotides (AG/GT) were conserved between the human and mouse genomes. However, a corresponding splice site was found in mouse for fewer than 2% of human sites, implying that noncoding exon orthologs are rare ( Figure 3C ). Although they were poorly conserved relative to their protein-coding counterparts, noncoding exons exhibited internal sequence constraint (base on Vertebrate PhlyoP scores) comparable with annotated DNase hypersensitive or transcription factor binding sites, with flanking splice sites showing a further, though relatively modest, conservation enrichment ( Figures  S12A and S12B) . These data indicate that, while similar in size and structure, human and mouse noncoding RNA populations are largely distinct, echoing the reported divergence of regulatory elements between mouse and human genomes Villar et al., 2015) .
Human Chromosome 21 Expression and Splicing in Mouse Cells
The Tc1 mouse strain is a model for trisomy-21 that carries a stable copy of Hsa21 (Yu et al., 2010) . The Tc1 mouse has also been used to compare the human and mouse transcriptomes, enabling the regulatory contributions of human cis elements and mouse trans-acting factors to be distinguished (Barbosa-Morais et al., 2012; Wilson et al., 2008) . To investigate the regulation of transcriptome diversity, we performed short-read RNA CaptureSeq, targeting both Hsa21 and its syntenic mouse genome regions, in matched tissues of the Tc1 mouse (Table  S9 and STAR Methods).
Most notably, the splicing profiles of genes encoded on Hsa21 were recapitulated in the Tc1 mouse as for human tissues, rather their mouse orthologs, where these were divergent. The DYRK1A gene again provides an illustrative example, with human-specific splice-site selection and quantitative exon usage faithfully recapitulated on Hsa21 in Tc1 samples ( Figures  4A-4D) . Globally, 87% of human-specific splice sites distinguishing human and mouse orthologs were also detected on Hsa21 in the Tc1 mouse (compared with 82% for shared splice sites; Figure S13A) . Similarly, the alternative splicing frequency of human exons remained 2.1-fold higher than for mouse orthologs, and 88% of sites classified as alternative in human were also classified as alternative in Tc1 (compared with 39% in mouse; Figures S13B and S13C). When correlated according to the PSI profiles across all orthologous splice sites, we found that human, mouse, and Tc1 samples clustered according to chromosomal, rather than organismal, origin ( Figure S14C ). Together these data confirm the central importance of local cis sequence elements in defining exon boundaries and alternative exon inclusion.
The structure and splicing of lncRNAs encoded on Hsa21 was also precisely recapitulated in the Tc1 mouse, despite the absence of mouse orthologs. The majority (85%; Figure 4E ) of human noncoding splice sites were also detected in Tc1 and noncoding exons were again near universally alternatively spliced (98%; Figures 4A-4C ). Furthermore, quantitative splice-site usage and relative noncoding isoform abundance was maintained as for human tissues (Figure 4D) , indicating that the local Hsa21 sequence is sufficient to establish splicesite position and regulate the proportional inclusion of noncoding exons by alternative splicing.
In contrast to splicing, we observed a global deregulation of expression in the Tc1 mouse, as assessed by principal component analysis or rank-correlation clustering (Figures S14A and S14B). This effect is best illustrated at intergenic regions flanking the NCAM2 locus, where numerous lncRNA genes that are silenced in the human brain become deregulated, resulting in aberrant expression in the Tc1 mouse brain ( Figure S15A ). In fact, the expression of human protein-coding genes encoded on Hsa21 was more similar to expression of their mouse orthologs in corresponding mouse tissues than to the expression of the same human genes encoded on Hsa21 in the Tc1 mouse ( Figures S14A and S14B ). This deregulation was restricted to the human chromosome, with tissue-specific expression profiles still maintained across syntenic regions of the mouse genome in Tc1 mouse ( Figure S15B) . This analysis appears to highlight a distinction in the evolution of expression and splicing regulation. The deregulation of human gene expression in mouse cells is consistent with the reported divergence of human and mouse regulatory elements, including enhancers and transcription factor binding sites Villar et al., 2015) . In contrast, splicing profiles were largely recapitulated on Hsa21 in the Tc1 mouse, as has been observed previously for protein-coding exons (Barbosa-Morais et al., 2012) . This implies that splicing is largely regulated by cis elements in the local chromosome sequence (Barash et al., 2010) and can be correctly interpreted by the mouse spliceosome. Our findings imply that the splicing code is so highly conserved that human-specific exons and noncoding RNAs without orthologs in mouse are correctly spliced. This demonstrates deep conservation of the lexicon that governs splicing, even while the isoforms produced undergo rapid diversification and turnover.
DISCUSSION
To overcome the expression-dependent bias in RNA-seq, which impedes discovery and characterization of low-abundance tran-scripts (Hardwick et al., 2016) , we performed targeted RNA-seq across human chromosome 21. The combination of single-molecule and short-read RNA CaptureSeq enabled accurate resolution of isoform diversity and quantitative analysis of alternative splicing at unprecedented depth.
Noncoding loci are, contrary to the impression from more shallow surveys (Cabili et al., 2011; Derrien et al., 2012) , enriched for alternative splicing, with noncoding exons being near universally classified as alternative. This finding is consistent with previous reports of lower splicing efficiency and U2AF65 occupancy among lncRNAs than mRNAs, features independently correlated with heightened alternative over constitutive splicing (Melé et al., 2017; Mukherjee et al., 2017; Tilgner et al., 2012) .
Therefore, while protein-coding genes are constrained by the requirement to maintain an ORF, it appears that no similar constraint is imposed on noncoding RNA. This suggests that noncoding exons are functionally modular, operating as discrete cassettes that are recombined with maximum flexibility. One can envision a scenario where individual noncoding exons interact independently with other biomolecules (proteins, RNAs, and/or DNA-motifs), organizing these around the scaffold of a noncoding transcript. In this way, alternative isoforms could assemble different collections of binding partners to dynamically regulate cellular processes. The distinction between protein-coding and noncoding RNA was also evident when comparing exons within ORFs with untranslated regions of coding loci (located in 5 0 or 3 0 UTRs, or specific to noncoding isoforms), implying similar modularity in the functional architecture of untranslated regions.
Low expression is often cited as evidence against the functional relevance of novel transcripts, such as the wide variety of rare noncoding isoforms identified in our survey. However, while weakly expressed genes/isoforms are unlikely to fulfill structural or metabolic functions, there are precedents for these fulfilling regulatory roles. For example, Marinov et al. (2014) found the mRNAs of expressed transcription factors to be present, on average, at just 3 copies per cell within a homogeneous cell line (GM12878). Single-cell studies routinely reveal rare cell types within human tissues on the basis of their unique gene expression profiles. These may be represented by just a few cells within a community of hundreds or thousands of cells (Grun et al., 2015; La Manno et al., 2016; Muraro et al., 2016) . Given that mRNAs encoding regulatory molecules such as transcription factors are expressed at only a few copies per cell, the regulatory factors that define the identity of rare cell types are expected to be present at very low frequencies in wholetissue transcriptomes. It would be premature, therefore, to discount the relevance of any transcript on the basis of low abundance alone.
Moreover, while not every rare isoform is necessarily important, and the promiscuous splicing we observed might simply reflect a lack of selective pressure, noncoding RNAs collectively form a large reservoir of transcriptional diversity from which molecular innovations might evolve and new genes may be born (Kaessmann, 2010; Toll-Riera et al., 2009; Wu et al., 2011; Xie et al., 2012) . The use of alternative splicing to generate noncoding transcriptional diversity and, thereby, drive gene evolution is consistent with the divergence of noncoding exons reported here. By contrast, the splicing code that governs such transcriptional diversity remains closely conserved between human and mouse.
Despite concerted efforts over the past decade, we are yet to achieve a complete census of human gene expression. Even our use of targeted single-molecule RNA-seq was insufficient to resolve the full complement of noncoding isoforms encoded on Hsa21. Instead, we found a seemingly limitless diversity of noncoding isoforms. Given the range of combinatorial possibilities, we suggest that the noncoding RNA population may be inherently plastic, and that there does not exist a finite list of noncoding isoforms that can be feasibly cataloged.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human Samples
Total RNA samples from healthy adult tissues were acquired from a commercial vendor (Ambion Human RNA Survey Panel). Ambion certifies that all of human-derived materials have been prepared from tissue obtained with consent from a fully informed donor or a member of the donor's family. Two replicate samples for human brain and kidney, and three replicates for testis were analyzed.
Mouse Samples
All animals were handled, housed, and used in the experiments in accordance with protocols approved by the Animal Ethics Committee of The University of Queensland, Brisbane, Australia. Three male mice (C57BL/6J x 129S8/SvEv) and 3 Tc1 female breeders were imported from the Jackson Laboratory, Maine, USA. 10 x F1 pups produced from paired mating were toed for identification and genotyping. Genotyping was performed on gDNA extracted from toe tissues using primers specific to human and mouse JAM2 genes. Three Tc1 F1 males and 3 WT littermates were sacrificed between 6 and 9 weeks of age, and testis, kidney and brain tissues were immediately harvested in TRIzol reagent (Ambion), snap-frozen on dry ice and stored at -80 C until processing.
K562 Cells
The human lymphoblast cell line, K562, was obtained from the American Type Culture Centre (ATCC). Cells were not independently verified or tested for mycoplasma. Cells were cultured according to Coriell Institute's growth protocols and standards. Briefly, K562 cells were cultured in RPMI 1640 medium (Gibco) supplemented with 10% FBS at 37 C under 5% CO 2 . Cells (passage 9 or 10) were grown to 80% confluence before RNA extraction.
METHOD DETAILS
Total RNA Extraction Mouse Samples Tissue samples (brain, kidney and testis), harvested in trizol and snap-frozen (see above), were defrosted on ice and 125 mg MicroBeads (MoBio) were added to sample tubes. Tissues and cells were disrupted by 2 cycles of 45 sec at 6500 rpm on a tissue homogenizer (Precellys) connected to a cooling system (Cryolis) keeping the samples temperature < 4 C during the cell lysis procedure. Bead-free cell lysates were transferred to a new 1.5 mL tube and RNA was immediately harvested, as above. Brain RNA was extracted a second time in TRIzol due to high lipid contamination present after the first extraction.
K562 Cells
Total RNA was extracted in 3mL TRIzol reagent (Ambion). Extraction of the aqueous phase was performed using chlorophorm and RNA precipitation was achieved with isopropanol. RNA pellets were washed in ice-cold 75% EtOH and allowed to dry before suspension in DEPC-treated H 2 O.
Capture Enrichment
Oligonucleotide probes targeting the entire non-repetitive portion of Hsa21 (hg19) and its syntenic regions in the mouse (mm10) genome, obtained using the UCSC Genome Browser liftOver tool, were designed and synthesized by Roche/NimbleGen. In total, the array targeted 25.3 Mb encompassing 0.87% of the human genome and 20.3 Mb encompassing 0.77% of the mouse genome.
Total RNA samples were assessed for potential gDNA contamination by PCR and accordingly treated with Turbo DNAse (Ambion). Samples were spiked with ERCC RNA spike-in controls (Jiang et al., 2011) to a final 1% concentration and rRNA-depleted using the Ribo-Zero rRNA removal magnetic kit (Epicentre). cDNA libraries were prepared from rRNA-depleted samples using the Illumina TruSeq stranded mRNA low-template kit. Pre-capture LMPCR amplified libraries were purified using AMPure XP beads (Beckman Coulter Genomics), and successful library preparation was validated using a DNA 1000 kit (Agilent) on a Bioanalyser. Average library sizes were 280-310 bp.
Capture hybridization was performed in 96-well plates, with hybridization probes incubated at 47 C for 64-77 h. Post-capture LMPCR amplification was performed for 17 cycles. Amplified post-capture libraries were purified using AMPure XP beads, and validated using a DNA 1000 kit on a Bioanalyzer. Samples that retained unincorporated primers were cleaned a second time using a QIAquick PCR purification kit (Qiagen), and successful primer removal was validated on a Bioanalyzer. For a detailed protocol see (Mercer et al., 2014) .
PacBio SMRTbell Library Preparation and Single-Molecule Sequencing
A total of 4.5 mg of captured full-length cDNA was subjected to size fractionation using the Sage Science BluePippin system into four size bins (0-2kb, 1-3kb, 3-6kb and 4-10kb). Eluted size fractions were subsequently re-amplified and purified with AMPure PB beads. Size distributions of the fractions were checked for quality on a 2100 BioAnalyzer (Agilent).
Approximately 10 mg of purified amplicon was taken into Iso-Seq SMRTBell library preparation (https://pacbio.secure.force.com/ SamplePrep). Separate SMRTbell libraries were generated for each of the four size bins (Table S10 ). Two of the SMRTBell libraries (3-6kb and 4-10kb) were size-selected again using the Sage Science BluePippen system to remove trace amounts of small inserts. A total of 24 SMRT Cells (6 cells for each of the size-selected SMRTBell library) were sequenced on the PacBio RS II platform using P6-C4 chemistry with 3 to 4 hour acquisition time.
Short-Read (Illumina) Sequencing
Short-read sequencing libraries were prepared with the Illumina TruSeq stranded mRNA low-template kit. Libraries were sequenced at the Garvan Institute (Sydney, NSW, Australia) on the Illumina HiSeq 2000 or Illumina HiSeq 2500 platforms, generating 2 x 101bp and 2 x 125bp paired-end sequencing, respectively.
QUANTIFICATION AND STATISTICAL ANALYSIS
Validation of Hsa21 RNA CaptureSeq in K562 Cells
To establish the Hsa21 CaptureSeq approach we first carried out short-read sequencing (Illumina HiSeq 2000) on Hsa21-enriched libraries from the human K562 cell-type (n = 3) and compared these to K562 samples analyzed in parallel by conventional RNA-Seq (n = 3; Table S1 ).
Sequencing libraries were trimmed using TrimGalore (https://www.bioinformatics.babraham.ac.uk-/index.html; default parameters), then aligned to a combined index of the hg19 reference genome and ERCC spike-in sequences. Alignment was performed by STAR (Dobin et al., 2013) with the following custom parameters:
-twopassMode Basic -outFilterIntronMotifs RemoveNoncanonical -alignIntronMin 20 -alignIntronMax 500000 y On-target alignment rates were calculated by determining the number of uniquely mapped reads (MapQ=255) within Hsa21, as a fraction of all uniquely mapped reads across hg19. The average fold-increase in on-target rate for CaptureSeq samples, relative to non-captured samples, provides an estimate of the coverage enrichment achieved by capture (Table S1 ).
Relative abundances (in FPKM) of ERCC RNA spike-ins were determined using RSEM (Li and Dewey, 2011) , allowing the accuracy of transcript quantification to be assessed in captured/non-captured samples (Figures S2A and S2B ). Progressively decreasing enrichment at very high ERCC concentrations was observed due to saturation of CaptureSeq oligonucleotide baits, but is unlikely to affect transcripts within the physiological range of gene expression (Clark et al., 2015; Mercer et al., 2014) .
Single-Molecule Hsa21 Transcriptome Survey
To avoid potential artifacts associated with de novo transcript assembly, we analyzed Hsa21-enriched cDNA from human testis by deep single-molecule PacBio sequencing. Testis was selected because it provides a broad survey of gene-content encoded on Hsa21 (Soumillon et al., 2013) .
The PacBio Iso-Seq ''classify'' protocol was used to generate full-length, non-chimeric (FLNC) reads (https://github.com/ PacificBiosciences/cDNA_primer). Briefly, for each sequencing ZMW, a circular consensus sequence (CCS) was generated. Each CCS sequence was identified as full-length, non-chimeric if (1) both the 5' and 3' cDNA primer and the polyA tail preceding the 3' primer was identified at the two ends; and (2) the sequence does not contain cDNA primers or polyA tails in the middle of the sequence (indication of library artifacts). Because FLNC reads are supported by the presence of a polyA tail, they are considered to represent mature transcript isoforms. Resolution of both sequencing primers ensures that FLNC reads have been sequenced in completeness. However, the possibility of degradation due to the use of template switching without 5' cap capture means that some FLNC reads may not be biologically full-length.
FLNC reads were mapped to the human reference genome (hg19) using GMAP (Wu and Watanabe, 2005) and reads that mapped to Hsa21 with maximum mapping confidence (MapQ=40) were retained. In total, 387,029 reads aligned to Hsa21, constituting 910 Mb of usable transcript sequence concentrated in 1.5% of the genome (Figures S3A and S3B ; Tables S3 and 10) .
To retain only high-quality multi-exonic single-molecule transcripts, we next discarded: (1) transcripts with < 3 exons;
(2) transcripts that contained one or more non-canonical introns (based on AG/GT splice sites); (3) any transcript that was entirely contained as a partial fragment of a longer transcript or an annotated transcript (based on internal exon-intron-exon chain); (4) any transcript with the following CuffCompare classifier: e, i, o, p, r, s (Trapnell et al., 2012) . After filtering, we retrieved 101,478 full-length multi-exonic transcripts ( Figure S3B ; Table S3 ). To our knowledge, this represents the deepest single-molecule transcriptome survey of a large genome region ever performed.
Transcripts were next assessed for overlap with known protein-coding genes. Transcripts that shared exonic overlap (on the same strand) with a known gene but not an identical internal exon-intron-exon chain were considered to represent novel isoforms of known genes. Redundant transcripts (sharing identical internal exon-intron-exon chains) were collapsed.
These were classified as protein-coding or noncoding via the Coding Potential Assessment Tool (Wang et al., 2013 ; longest ORF R 100 codons, coding potential score R 0.99). For coding transcripts we used TransDecoder to predict ORFs. Redundant ORFs and fragments fully contained within longer ORFs were discarded. ORFs were overlapped with full-length transcripts to distinguish coding exons from noncoding exons belonging to coding loci, including spliced UTR exons and exons incorporated exclusively into noncoding isoform variants at coding loci.
Transcripts that shared no exonic overlap with a known protein-coding gene (Gencode v19) and lacking a predicted ORF (CPAT; longest ORF < 100 codons, coding potential score < 0.99) were classified as lncRNA transcripts. Redundant transcripts (sharing identical internal exon-intron-exon chains) were collapsed.
Short-Read Hsa21 RNA CaptureSeq in Human Tissues
To obtain quantitative information about transcripts in our single-molecule Hsa21 profile, short-read sequencing (Illumina HiSeq 2500) was performed on duplicate Hsa21-enriched libraries from brain, kidney and testis. Sequencing libraries were trimmed and aligned as described above (see above). On-target alignments rates were calculated as above (see 3.1) and reads that were uniquely mapped (MapQ=255) within Hsa21 were retained for further analysis. At least 100 million alignments to Hsa21 were obtained for each tissue (Table S4) .
Because de novo transcript assembly from short sequencing reads may generate incorrect transcript models, especially for lowabundance isoforms (Hardwick et al., 2016) , we did not perform transcript assembly. For all analyses of human tissues, the singlemolecule PacBio transcriptome described above (see above) was used as a reference, with spliced-short read alignments used to quantitatively evaluate expression and splicing of PacBio transcripts.
The majority of spliced short-read alignment junctions were concordantly mapped to an intron in our single-molecule Hsa21 transcriptome profile ( Figure S3B) . Likewise, the majority of unique internal exons in our single-molecule Hsa21 transcriptome were correctly detected (both boundaries specified by R 3 spliced short-read alignment termini) in at least one tissue ( Figure S3C ). This concordance with more accurate short-reads (Conesa et al., 2016) suggests that single-molecule isoforms were, in general, correctly aligned to Hsa21, and their internal exon-intron-exon architecture was correctly resolved.
Discovery Saturation Curves
To generate discovery-saturation curves, short-read alignments from brain, kidney and testis were combined, then incrementally subsampled from a maximum of 450 million alignments. We assessed the detection of introns and exons within our single-molecule Hsa21 transcriptome by short-read alignments at each depth-increment. The analysis was limited to unique canonical introns and unique internal exons (as opposed to terminal exons) since these should be precisely demarcated by short-read alignment junctions at either end. An internal exon from our transcriptome was considered to be detected within a given library if both boundaries were specified by R 3 spliced short-reads. An intron from our transcriptome was considered to be detected within a given library if it was spanned by R 3 spliced short-read alignment junctions, mapping exactly to its 5' and 3' ends.
Percent Splice Inclusion (PSI) Values
To further assess alternative splicing, we calculated a Percent Splice Inclusion (PSI) score for each internal exon in our Hsa21 transcriptome, as has been done previously (Barbosa-Morais et al., 2012; Tilgner et al., 2015) . For each exon, we counted spliced reads that used its 5' splice site (In 1 ) and 3' splice site (In 2 ) and spliced reads that spanned/skipped the exon (Out). The PSI value for that exon was then calculated as:
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We confirmed that the occurrence of lower inclusion frequencies among noncoding exons (median PSI = 55.5%) than protein-coding exons (median PSI = 90.5%; Figure 2B ) was not simply caused their lower gene expression, since exon-PSI and overall gene expression metrics were independent from one and other ( Figure S7 ). Applying a threshold of PSI > 95% to distinguish constitutive from alternatively spliced exons, as has been done previously (Barbosa-Morais et al., 2012; Tilgner et al., 2015) , almost all noncoding exons (97%) would be classified as alternative. We note that the use of a single, essentially arbitrary, PSI threshold is simplistic. However, this difference was indicative of a clear, population-wide depletion of PSI scores among noncoding exons, relative to their protein-coding counterparts, with a clear difference observable at any chosen threshold ( Figure 2B ). The use of PacBio reads as a scaffold for calculating PSI scores ensures we are working with accurate transcripts (free of potential artifacts from transcript assembly). However, PacBio reads are less suitable for quantitative analyses because (i) size fractionation and heavy PCR amplification during the PacBio library preparation may distort transcript abundances within the population and (ii) saturating read-depth is required for accurate analyses of splicing. Therefore we consider our combined approach to be the most reliable way to assess alternative splicing. PSI scores were also calculated independently using only spliced PacBio long-read alignments, rather than spliced short-reads. This analysis produced similar results ( Figure S9 ).
Comparison of Human and Mouse Transcriptomes
To perform a fair comparison of transcriptome dimensions between human and mouse profiles, we generated de novo transcriptome assemblies for each, at matched depth, rather than using the single-molecule human transcriptome (which would skew the comparison, since long-read sequencing was not performed on mouse tissues). While we note that de novo assembly may produce some spurious transcript models, the comparison of transcriptome dimensions between human and mouse is fair, since biases should affect both assemblies equally. Additionally, because assemblies were generated without the support of reference gene catalogs, they are not affected by discrepancies in the quality/completeness of human/mouse genome annotation.
After aligning reads to hg19 or mm10 with STAR and retaining only on-target, uniquely mapped reads (see above), libraries were subsampled to achieve a maximum matched depth of 100 million alignments per tissue (Tables S4 and S7 ). Assemblies were generated from these matched libraries using StringTie (Pertea et al., 2015) . Assemblies from replicates for each tissue were merged using Cuffmerge (Trapnell et al., 2012) . Full-length assembled transcript sequences were filtered and classified as above (see above).
